Skip to main content
Future Students
Current Students
Apply to UWI
Programme Search
Campus Life
Research & Innovation
Faculties/Academics
Libraries
Online Systems
Student Administration System
Student Portal
OurVLE
Bursary Online Student System (BOSS)
Online Tuition Payment
Online Transcript Request
ASKMONA: Library Virtual Reference Service
UWILINC
Student Services
Office of Student Financing
Bookshop
Mona Information Technology Services
Campus Registrar
Campus Security
Guild of Students
Graduate Studies & Research Information Portal
Health Services
The Office of Student Services
Registration & Fees
Schedules
Undergraduate Fees
Graduate Fees
Financial Aid
Online Support
Password Self Service
Select a Campus
Cave Hill
Five Islands
Global Campus
St. Augustine
Mona
UWI Centre
Select a Campus
Cave Hill
Five Islands
Global Campus
St. Augustine
Mona
UWI Centre
Visit UWI
Email
Directory
Campus Map
Help
The University of the West Indies, Mona
West Indian Medical Journal
ISSN: 2309-5830
Home
About
About WIMJ
Editorial Board
Creative Commons
WIMJ Open
FAQ
Instructions for Authors
Publications
Recent Issues
Published Ahead of Print
Supplements
Archives
Search
Contact
Login
UWI
/
Mona
/
West Indian Medical Journal
lamivudine
A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy
Issue:
Vol 64, Issue 3: June (2015)
DOI:
10.7727/wimj.2014.066
Pages:
291–3
ABSTRACT
Received:
12 Mar, 2014
Accepted:
14 Apr, 2015
PDF Attachment:
wimjjun2015_291_293.pdf
Journal Sections:
Case Reports
Keywords:
raltegravir
HIV-1 infection
lamivudine
Darunavir
ritonavir
severe lipodystrophy
Journal Authors:
A Degli Antoni
LE Weimer
V Fragola
A Giacometti
F Sozio
e-Published:
14 Jul, 2015
Read more
about A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy
Investigation by the Method of INNO-LiPA of Primary Resistance to Lamivudine in Patients with Chronic Hepatitis B Who Have Not Used Antiviral Therapy
Issue:
Vol 65, Issue 1: 2016
DOI:
10.7727/wimj.2014.291
Pages:
111–5
Synopsis:
Lamivudine, an effective oral antiviral agent, inhibits the replication of hepatitis B virus by blocking reverse transcriptase enzyme. Administering lamivudine is an effective and convenient method of early treatment.
ABSTRACT
Received:
15 Oct, 2014
Accepted:
29 Oct, 2014
PDF Attachment:
wimj_iss1_2016_111_115.pdf
Journal Sections:
Original Articles
Keywords:
Chronic hepatitis B
lamivudine
innolipa
primary resistance
Journal Authors:
M Özgüler
A Akbulut
K Demirdağ
M Özden
e-Published:
30 Apr, 2015
Read more
about Investigation by the Method of INNO-LiPA of Primary Resistance to Lamivudine in Patients with Chronic Hepatitis B Who Have Not Used Antiviral Therapy
A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation
Issue:
Vol 63, Issue 7: Dec (2014)
DOI:
10.7727/wimj.2013.264
Pages:
779–84
ABSTRACT
Received:
19 Sep, 2013
Accepted:
28 Nov, 2013
PDF Attachment:
wimjdec2014_779_784.pdf
Journal Sections:
Case Reports
Keywords:
raltegravir
HIV-1
liver transplantation
lamivudine
viral hepatitis
Journal Authors:
O Cirioni
LE Weimer
V Fragola
A Giacometti
F Ancarani
M Maracci
E Gabrielli
E Marchionni
MF Pirillo
S Vella
e-Published:
03 Sep, 2014
Read more
about A Simplified HAART Regimen with Raltegravir and Lamivudine, and Pharmacokinetic Interactions with a Combined Immunosuppressive Therapy with Tacrolimus and Everolimus in an HIV/HCV/HBV/HDV Patient after Liver Transplantation
Top of Page